ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 164 filers reported holding ADMA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,479,542 | -3.3% | 5,999,872 | -0.3% | 3.17% | +5.2% |
Q2 2023 | $22,204,841 | +11.5% | 6,017,572 | +0.0% | 3.01% | +11.8% |
Q1 2023 | $19,909,650 | -14.7% | 6,015,000 | 0.0% | 2.69% | -19.9% |
Q4 2022 | $23,338,200 | +91.5% | 6,015,000 | +19.9% | 3.36% | +81.6% |
Q3 2022 | $12,186,000 | +22.7% | 5,015,000 | 0.0% | 1.85% | +18.5% |
Q2 2022 | $9,930,000 | +16.0% | 5,015,000 | +7.2% | 1.56% | +41.8% |
Q1 2022 | $8,564,000 | +32.6% | 4,680,000 | +2.2% | 1.10% | +70.2% |
Q4 2021 | $6,458,000 | – | 4,579,900 | – | 0.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 5,269,155 | $12,804,000 | 12.70% |
Stonepine Capital Management, LLC | 5,000,000 | $12,150,000 | 5.46% |
Altium Capital Management LP | 2,883,710 | $7,007,000 | 2.57% |
AWM Investment Company, Inc. | 5,015,000 | $12,186,000 | 1.85% |
Potomac Capital Management, Inc. | 482,000 | $1,171,000 | 1.34% |
Perceptive Advisors | 10,933,387 | $26,568,000 | 0.77% |
EAM Investors, LLC | 1,427,160 | $3,468,000 | 0.75% |
Clearline Capital LP | 2,496,297 | $6,066,000 | 0.72% |
EAM Global Investors LLC | 836,323 | $2,032,000 | 0.54% |
BOOTHBAY FUND MANAGEMENT, LLC | 8,121,153 | $19,734,000 | 0.49% |